{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:50:51Z","timestamp":1790351451397,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K12HD103083-01"],"award-info":[{"award-number":["1K12HD103083-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020253","name":"Kay Yow Cancer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","award":["UM1CA239755"],"award-info":[{"award-number":["UM1CA239755"]}],"id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijgc.2026.104727","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:13:32Z","timestamp":1777580012000},"page":"104727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium study"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4452-8694","authenticated-orcid":false,"given":"Angela","family":"Nolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8927-5830","authenticated-orcid":false,"given":"Morgan D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-9303","authenticated-orcid":false,"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1636-5277","authenticated-orcid":false,"given":"Kyle C.","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-1365","authenticated-orcid":false,"given":"Sarah","family":"Bean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadee L.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Pothuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5803-0718","authenticated-orcid":false,"given":"Kathleen N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2551-760X","authenticated-orcid":false,"given":"Leslie H.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried","family":"Konecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2830-5116","authenticated-orcid":false,"given":"Kari","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2482-8860","authenticated-orcid":false,"given":"Christina","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premal","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Larry","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Berchuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles Alvarez","family":"Secord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-9120","authenticated-orcid":false,"given":"Rebecca A.","family":"Previs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijgc.2026.104727_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104727_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104727_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","article-title":"Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review","volume":"95","author":"Ramirez","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"19","key":"10.1016\/j.ijgc.2026.104727_bib4","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104727_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00404-013-2826-8","article-title":"A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women","volume":"288","author":"Shan","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104727_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ygyno.2021.04.017","article-title":"Updates on conservative management of endometrial cancer in patients younger than 45 years","volume":"161","author":"Lucchini","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104727_bib7","doi-asserted-by":"crossref","first-page":"191.e1","DOI":"10.1016\/j.ajog.2020.08.032","article-title":"Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer","volume":"224","author":"Westin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104727_bib8","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ijgc-2020-001309","article-title":"Improving response to progestin treatment of low-grade endometrial cancer","volume":"30","author":"Baxter","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104727_bib9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ajog.2024.07.018","article-title":"Fertility-preserving treatment for stage IA endometrial cancer: a systematic review and meta-analysis","volume":"231","author":"Suzuki","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijgc.2026.104727_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejogrb.2019.07.013","article-title":"Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: outcomes from an institutional series","volume":"240","author":"Falcone","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104727_bib11","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3390\/cancers13112847","article-title":"Molecular classification to prognosticate response in medically managed endometrial cancers and endometrial intraepithelial neoplasia","volume":"13","author":"Puechl","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijgc.2026.104727_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.810631","article-title":"Molecular classification in patients with endometrial cancer after fertility-presesrving treatment: application of ProMisE classifier and combination of prognostic evidence","volume":"12","author":"Ran","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijgc.2026.104727_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154278","article-title":"Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia","volume":"241","author":"Zhang","year":"2023","journal-title":"Pathol Res Pract"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104727_bib14","doi-asserted-by":"crossref","first-page":"370.e1","DOI":"10.1016\/j.ajog.2020.10.003","article-title":"Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer","volume":"224","author":"Chung","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104727_bib15","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2024.35.e27","article-title":"Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia","volume":"35","author":"Lv","year":"2024","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2026.104727_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2024.04.013","article-title":"Mismatch repair deficiency and abnormal p53 expression has significant predictive value for progesterone resistance and endometrial tumorigenesis in patients with endometrial atypical hyperplasia receiving fertility-preserving treatment","volume":"186","author":"Peng","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104727_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2024.100024","article-title":"The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment","volume":"35","author":"De Vitis","year":"2025","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104727_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/curroncol32060317","article-title":"Molecular classification guides fertility-sparing treatment for endometrial cancer and atypical hyperplasia patients","volume":"32","author":"Wang","year":"2025","journal-title":"Curr Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104727_bib19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104727_bib20","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3390\/cancers13061478","article-title":"The TCGA molecular classification of endometrial cancer and its possible impact on adjuvant treatment decisions","volume":"13","author":"Alexa","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.ijgc.2026.104727_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.mpdhp.2021.09.003","article-title":"Endometrial carcinoma: changes to classification (WHO 2020)","volume":"27","author":"Masood","year":"2021","journal-title":"Diagn Histopathol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104727_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.101758","article-title":"Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study","volume":"35","author":"Secord","year":"2025","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2026.104727_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygyno.2025.01.006","article-title":"Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: ancillary analysis of GOG-0258","volume":"193","author":"Clements","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"7447","key":"10.1016\/j.ijgc.2026.104727_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104727_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104727_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/ijgc-2022-003772","article-title":"Update in the molecular classification of endometrial carcinoma","volume":"33","author":"L\u00e9on-Castillo","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104727_bib27","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/cancers15051400","article-title":"Lynch syndrome and gynecologic tumors: incidence, prophylaxis, and management of patients with cancer","volume":"15","author":"Capasso","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104727_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/107327480901600103","article-title":"Endometrial cancer and Lynch syndrome: clinical and pathologic considerations","volume":"16","author":"Meyer","year":"2009","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104727_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2017.12.009","article-title":"Racial disparities in molecular subtypes of endometrial cancer","volume":"149","author":"Dubil","year":"2018","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:49:45Z","timestamp":1785790185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26002586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1048891X26002586"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104727","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"104727"}}